Etavopivat showed a 27% reduction in vaso-occlusive crisis events and ~4-month delay to first vaso-occlusive crisis event on ...
Denmark’s employed workforce shrank for the first time since mid-2024, as layoffs at Novo Nordisk A/S began to show up in ...
On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No ...
FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS/Tom Little/File Photo ...
Novo Nordisk said April 23 it plans to seek expanded FDA approval for its Ozempic pill in the second half of 2026, which would make the drug the first oral GLP-1 approved for children and adolescents ...
The two themes aim to generate knowledge that can help develop energy-efficient biosolutions and explore alternatives to scarce resources that can help reduce fossil emissions while strengthening ...
Hi, this is Charles in Stockholm. Welcome to our weekly newsletter on what’s shaping economies and investments from the Arctic to the Baltic Sea. You can subscribe here. While the Danish economy looks ...
Bangladesh has entered a new phase in diabetes care as Eskayef Pharmaceutical Limited and Novo Nordisk on Tuesday launched ...
Novo Nordisk, the Danish leading global healthcare company, marked an important milestone in Pakistan by launching its “Live ...
Feb 23 (Reuters) - Novo Nordisk shares slumped by more than 16% on Monday, wiping away the remaining gains brought by its blockbuster weight-loss drug Wegovy, after the drugmaker said its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results